Literature DB >> 35635597

Chromatic visual evoked potentials identify optic nerve dysfunction in patients with Graves' orbitopathy.

Yueqi Yu1,2,3, Bingjie Shi3, Shengnan Cheng3, Yushuai Liu3, Ru Zhu3, Yayan You3, Jin Chen3, Xiaohuan Pi3, Xinghua Wang4, Fagang Jiang5.   

Abstract

PURPOSE: To explore visual dysfunction in Graves' orbitopathy (GO) objectively by analyzing chromatic visual evoked potentials (cVEP) and evaluate its diagnostic efficiency for dysthyroid optic neuropathy (DON).
METHODS: In this cross-sectional study, we analyzed pattern-reversal VEP (pVEP), red-green (R-G) and blue-yellow (B-Y) cVEP in 93 subjects (21 with DON, Group A, 30 with GO, Group B, and 42 healthy controls, Group C) at Wuhan Union Hospital, China.
RESULTS: Compared with Group C, the amplitudes of B-Y cVEP were significantly lower in Group B, whereas all amplitudes of cVEP, latencies and amplitudes of pVEP in Group A were significantly impaired. In addition, the pVEP latency at 60 arcmin (60'), pVEP amplitudes and R-G cVEP amplitudes were significantly different between Group A and B. Moreover, 60'cVEP R-G negative-positive (N-P) amplitude was correlated with crowding index (P = 0.001), the average thickness of ganglion cell layer and inner plexiform layer (P = 0.004). Furthermore, combination of 60'cVEP R-G amplitude and 60'pVEP P100 latency had better diagnostic efficiency than each single parameter, with optimal cut-off values of 14.20 μV and 110.65 ms, respectively.
CONCLUSION: GO may induce electrophysiological changes. The presence of B-Y cVEP anomalies in moderate to severe GO patients may be an early sign of preclinical DON. A decline in 60'cVEP R-G amplitude is associated with apical crowding and thinner inner intra-retinal layers. The combination of 60'cVEP R-G N-P amplitude and 60'pVEP latency can be a useful diagnostic index for DON.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Chromatic; Dysthyroid optic neuropathy; Graves’ orbitopathy; Visual evoked potentials

Year:  2022        PMID: 35635597     DOI: 10.1007/s10792-022-02369-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  25 in total

1.  Development, maturation, and aging of chromatic visual pathways: VEP results.

Authors:  Michael A Crognale
Journal:  J Vis       Date:  2002       Impact factor: 2.240

2.  Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy.

Authors:  Shu Lang Liao; Tien Chun Chang; Luke L-K Lin
Journal:  Am J Ophthalmol       Date:  2006-03-09       Impact factor: 5.258

3.  Visual evoked potentials in three-dimensional color space: correlates of spatio-chromatic processing.

Authors:  J Rabin; E Switkes; M Crognale; M E Schneck; A J Adams
Journal:  Vision Res       Date:  1994-10       Impact factor: 1.886

4.  Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.

Authors:  David McKeag; Carol Lane; John H Lazarus; Lelio Baldeschi; Kostas Boboridis; A Jane Dickinson; A Iain Hullo; George Kahaly; Gerry Krassas; Claudio Marcocci; Michele Marinò; Maarten P Mourits; Marco Nardi; Christopher Neoh; Jacques Orgiazzi; Petros Perros; Aldo Pinchera; Susanne Pitz; Mark F Prummel; Maria S Sartini; Wilmar M Wiersinga
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

Review 5.  Evaluating Graves' orbitopathy.

Authors:  Peter J Dolman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

6.  Development of the temporal properties of visual evoked potentials to luminance and colour contrast in infants.

Authors:  M C Morrone; A Fiorentini; D C Burr
Journal:  Vision Res       Date:  1996-10       Impact factor: 1.886

7.  Comparison of the Farnsworth-Munsell 100-Hue, the Farnsworth D-15, and the L'Anthony D-15 desaturated color tests.

Authors:  C J Bassi; J C Galanis; J Hoffman
Journal:  Arch Ophthalmol       Date:  1993-05

8.  Blue-yellow and standard pattern visual evoked potentials in phakic and pseudophakic glaucoma patients and controls.

Authors:  Matthias Fuest; Jule Kieckhoefel; Babac Mazinani; David Kuerten; Antonis Koutsonas; Eva Koch; Peter Walter; Niklas Plange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-04       Impact factor: 3.117

9.  Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.

Authors:  Aylin Garip-Kuebler; Kathrin Halfter; Lukas Reznicek; Annemarie Klingenstein; Siegfried Priglinger; Christoph R Hintschich
Journal:  Br J Ophthalmol       Date:  2020-07-22       Impact factor: 4.638

Review 10.  Assessment of inherited colour vision defects in clinical practice.

Authors:  Barry L Cole
Journal:  Clin Exp Optom       Date:  2007-05       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.